MON-LB031 Higher Insulin Degrading Enzyme Levels in Subjects with Metabolic Syndrome

Background: With the growing prevalence of obesity, there is also a rise in the incidence of metabolic syndrome (MS). It is characterizes by hyperinsulinemia, increased fasting glucose, hypertriglyceridemia, low HDL, increased waist circumference and hypertension.Insulin-degrading enzyme (IDE) is th...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Endocr Soc
Prif Awduron: Sofer, Yael, Nash, Yuval, Forsht, Ofir, Osher, Esther, Nahary, Limor, Shaklai, Sigal, Tordjman, Karen, Serebro, Merav, Touati, Elia-Belle, Yacobi Bach, Michal, Marcus, Yonit, Tal, Brurya, Sack, Jessica, Sheffer, Gabi, Landis, Nathan, Stern, Naftali, Frenkel, Dan
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Endocrine Society 2019
Pynciau:
Diabetes Mellitus and Glucose Metabolism
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6550783/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-MON-LB031
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg